ProductsProprietary Products

HepaGam B

Therapeutic indication:

    1. Prevention of Hepatitis B recurrence following Liver Transplantation in HBsAg-positive liver transplant patients.
    2. Postexposure Prophylaxis in the following settings:
      • Acute Exposure to Blood Containing HBsAg
      • Perinatal Exposure of Infants Born to HBsAg-positive Mothers
      • Sexual Exposure to HBsAg-positive Persons
      • Household Exposure to Persons with Acute HBV Infection
  • Composition: Hepatitis B Immune Globulin Intravenous (Human) (HBIG)
  • Pharmaceutical form: Solution for infusion
  • Method of administration: Prevention: intravenous / PEP: intramuscular
  • Manufacturer: Kamada